logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回期刊详情
E

Expert Review of Pharmacoeconomics & Outcomes Research

IF1.5
论文数65
被引数
期刊论文 65
发表时间
delete
Estimated cost-effectiveness of adjuvant nivolumab for resected stage IIB-IIC melanoma in the United States在美国，辅助治疗中使用尼鲁单抗治疗切除后的IIB-IIC期黑色素瘤的成本效益评估
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-05-28
delete0
PREAI
deleteEljilany, Islam; Diaby, Vakaramoko
delete分享
delete收藏
Cost and clinical analysis of community-acquired pneumonia within an antimicrobial stewardship-governed academic hospital in South Africa, and its implications南非一家抗生素管理指导下的学术医院社区获得性肺炎的成本与临床分析及其影响
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-05-28
delete0
deleteOAAI
deleteBjang, Katlego; Kutume, Madimetje; Mongoai, Nthabiseng; Sebothoma, Boitshepo; Vagiri, Rajesh; Meyer, Johanna C.; Godman, Brian; Makhele, Letlhogonolo
delete分享
delete收藏
Estimating respiratory syncytial virus health utility values for older adults and their caregivers in the Japanese population: a time trade-off study估算日本老年人群及其照护者中呼吸道合胞病毒健康效用值：一项时间权衡研究
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-05-28
delete0
PREAI
deleteRendas-Baum, Regina; Bjorner, Jakob; Preckler, Victor; Matsuki, Taizo; Ho, Yufan; Molnar, Daniel; Noto, Shinichi; Igarashi, Ataru
delete分享
delete收藏
Antimicrobial resistance as an economic externality: optimal control, Pigouvian taxation, and governance implications抗菌素耐药性作为经济外部性：最优控制、庇古税及其治理意义
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-05-28
delete0
PREAI
deleteJana, Aritra; Khatua, Debnarayan; Mandal, Santi M.
delete分享
delete收藏
Analyzing the direct medical cost of schizophrenia in Hospital Pulau Pinang, Malaysia分析马来西亚槟城医院精神分裂症的直接医疗成本
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-05-28
delete0
PREAI
deleteAlotaibi, Fuad Fadhel; Alsuhibani, Abdulrahman A.; Ong, Siew Chin; Poh, Yih Chew; Alrasheed, Marwan A.; Alhomaidan, Ali
delete分享
delete收藏
Cost of care and budget impact of novel first-line treatments in patients with locally advanced or metastatic urothelial carcinoma from the Colombian healthcare system perspective局部晚期或转移性尿路上皮癌患者的新型一线治疗方案的成本及预算影响：从哥伦比亚医疗系统视角
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-04-21
delete0
deleteOAAI
deleteLasalvia, Pieralessandro; Jaramillo, Paola; Zapata, Maycos; Zapata, Martin; Gonzalez, Leonor; Hernandez, Veronica; Restrepo, Juliana
delete分享
delete收藏
The relationship between changes in prescription drug sales and changes in mortality and hospital utilization in Denmark, 2005-20192005-2019年丹麦处方药销售变化与死亡率和医院利用率变化之间的关系
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-04-21
delete0
PREAI
deleteLichtenberg, Frank R.
delete分享
delete收藏
Knowledge, perception and application of pharmacoeconomics among healthcare professionals in Malaysia马来西亚医疗保健专业人员对药物经济学的知识、认知和应用
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-04-01
delete0
PREAI
deleteChandriah, Haarathi; Low, Ee Vien; Ahmad, Nur Sufiza; Ahmat, Azmi Nor Mohd Farez; Farok, Izzati Mohd; Wong, Jacqueline Hui Yi; Fun, Weng Hong; Thanimalai, Subramaniam; Ng, Chin Hui; Ibrahim, Nor Haizan; Rosli, Mohd Rozaini; Lim, Kenneth Lik Chien; Choo, Yai Wen
delete分享
delete收藏
Burden Tree - a conceptual framework for the burden associated with pediatric infectious diseases: a Delphi approach负担树——与儿科传染病相关的负担的概念框架：一种德尔菲方法
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-04-01
delete0
PREAI
deleteCarias, Cristina; Riley, Danielle; Eiden, Amanda L.; Enstone, Ashley L.; Whittle, Isabelle J.; Marshall, Deanna B.; Oswald, Charlotte W.; Tilford, J. Mick
delete分享
delete收藏
Cost-effectiveness analysis of tucatinib plus trastuzumab versus pertuzumab plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer曲拉曲单抗联合曲妥珠单抗与帕妥珠单抗联合曲妥珠单抗治疗化疗耐药、HER2阳性、RAS野生型不可切除或转移性结直肠癌的成本效益分析
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteLiu, Mengmeng; Zhong, Lu; Dong, Mei; Liu, Tong
delete分享
delete收藏
Net benefits of investing in pulse oximetry and oxygen for childhood pneumonia in high burden countries在高负担国家为儿童肺炎投资脉搏血氧仪和氧气的净收益
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteColbourn, Tim; King, Carina
delete分享
delete收藏
Comparative cost per responder analysis of ciltacabtagene autoleucel and real-world standard of care therapy in patients with lenalidomide-refractory multiple myeloma来那度胺难治性多发性骨髓瘤患者中cilta-cabtagene autoleucel与真实世界标准治疗方案的每应答者比较成本分析
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteHansen, Doris K.; Lu, Xiaoxiao; Castaneda Puglianini, Omar; Zhang, Eileen; Usmani, Saad Z.; Sachdev, Rameet; Perciavalle, Matthew; De Wiest, Denise; Huo, Stephen; Lee, Seina; Qureshi, Zaina P.; Jagannath, Sundar
delete分享
delete收藏
Impact of early-stage immunotherapy on health and work productivity in the Czech Republic, 2024-2033早期免疫疗法对捷克共和国健康和劳动生产率的影响，2024-2033
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteBlezer, Gittan; Patterson, Karl; Micoch, Tomas; Alahakoon, Jana; Lai, Yizhen; Khurana, Vivek; Aguiar-Ibanez, Raquel
delete分享
delete收藏
Duration changes and decision-making in DCETTO: evidence from SF-6Dv2DCETTO框架中的持续时间变化与决策制定：SF-6Dv2的证据
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteAmeri, Hosein; Poder, Thomas G.
delete分享
delete收藏
Climate-related risk and pharmaceutical market dynamics in India and USA: evidence from transfer entropy, BEKK GARCH, and coherence wavelet印度和美国的气候相关风险与医药市场动态：基于转移熵、BEKK GARCH和相干小波的证据
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteHarikumar, Yedhu; Muralikrishna, Muthumeenakshi; Muralikrishna, Prakasam; Alola, Andrew Adewale
delete分享
delete收藏
Prevention, artificial intelligence, and mathematics in health economics: a framework for dynamic value modeling under long-term uncertainty预防、人工智能和数学在卫生经济学中的应用：长期不确定性下动态价值建模的框架
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteMaas, Lieke; Yaylali, Ayshe; Hiligsmann, Mickael
delete分享
delete收藏
Medication adherence research: expert perspectives on key HEOR trends for 2026用药依从性研究：2026年关键HEOR趋势的专家观点
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteAgh, Tamas; Borah, Bijan; Vervloet, Marcia; Hiligsmann, Mickael
delete分享
delete收藏
Cost-effectiveness analysis of point-of-care A1C tests in the primary care setting of Iran伊朗初级保健环境下即时A1C检测的成本效益分析
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteMousavi, Abdoreza; Raadabadi, Mehdi; Darvishi, Ali
delete分享
delete收藏
Trends in antidepressant utilization, expenditure, and demographic prescribing patterns in Jordan: a retrospective analysis抗抑郁药使用、支出及人口统计处方模式在约旦的趋势：一项回顾性分析
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteAl Twahya, Safa' F.; Hijazeen, Rima; Almomani, Hamzeh; Alefan, Qais; Alabbadi, Ibrahim
delete分享
delete收藏
Physicians' preferences for direct-acting antivirals in the treatment of chronic hepatitis C: evidence from a discrete choice experiment in China中国医生对慢性丙型肝炎直接抗病毒药物治疗偏好的研究：基于离散选择实验的证据
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteLi, Yan; Du, Junni; Tian, Chenhui; Ma, Aixia; Tao, Tiantian; Chen, Pingyu
delete分享
delete收藏